Glochem Industries is an API manufacturer based in India. It holds 18 active US drug master files across a filed portfolio of 10 molecules. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 28 June 2024 as VAI. Customs aggregates show $9.1M of exports covering 308 molecules to 44 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Sangareddy District, India | 3005818804 |
| Molecule | Regulators | Docs |
|---|---|---|
| Amlodipine | US FDA | 4 |
| Cetirizine | SFDA (Saudi Arabia), US FDA | 3 |
| Carbidopa | US FDA | 2 |
| Hydroxyzine | US FDA | 2 |
| Levocetirizine | US FDA | 2 |
| Raloxifene | US FDA | 2 |
| Telmisartan | US FDA | 2 |
| Eprosartan | US FDA | 1 |
| Levocetirizine Dihydrochloride | SFDA (Saudi Arabia) | 1 |
| Tolcapone | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $1.3M | 17 |
| 2025 | Not reported | $9.1M | 44 |
| 2024 | Not reported | $6.4M | 46 |
| 2023 | Not reported | $6.6M | 36 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Glochem Industries comes back tiered against every other supplier able to file there.
Start for free